ArticleBMC gastroenterology2017

CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFN/RBV.

Chia-Chen Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.